Dos Santos Wellington, Pereira Ariane S, Laureano Thais, de Andrade Edilene S, Reis Monise T, Garcia Felipe Ao, Campacci Natalia, Melendez Matias E, Reis Rui M, Galvão Henrique de Cr, Palmero Edenir I
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
Department of Genetics, Brazilian National Cancer Institute - INCA, Rio de Janeiro 20231-050, Brazil.
World J Gastroenterol. 2025 Aug 7;31(29):104830. doi: 10.3748/wjg.v31.i29.104830.
BACKGROUND: Adenomatous polyposis confers an increased risk of developing colorectal cancer. and are the major genes investigated in patients suspected of having polyposis. In addition to and genes, other genes, such as , and , have recently been associated with polyposis phenotypes, conferring heterogeneity in terms of the clinical, etiological and heritable aspects of patients with polyposis. AIM: To investigate the underlying variant landscape in patients with suspected polyposis who lack variants in the and genes using whole-exome sequencing. METHODS: Twenty-seven participants were included in the study and subjected to germline whole-exome sequencing. In addition, their clinical-pathological, personal, and family history data were collected. RESULTS: The mean age at diagnosis was 51 years, and most participants had attenuated forms of polyposis (88.9%), with 63.0% diagnosed with a primary tumor, mostly colorectal cancer (76.5%). Among the variants identified, 17 were classified as pathogenic or likely pathogenic (in 12 participants), including variants in genes involved in the Wnt/β-catenin signaling pathway, such as , , and , and variants in DNA-repair genes, such as , and , as well as a variant found at the gene identified in a patient with classic polyposis at age 19 and with a family history of polyps. CONCLUSION: This study identified novel genes potentially associated with polyposis in patients lacking germline pathogenic variants in the and genes. These findings support the use of next-generation sequencing for screening, expanding the scope of polyposis-related variants beyond these two genes.
背景:腺瘤性息肉病会增加患结直肠癌的风险。[基因名称1]和[基因名称2]是怀疑患有息肉病患者中主要研究的基因。除了[基因名称1]和[基因名称2]基因外,其他基因,如[基因名称3]、[基因名称4]和[基因名称5],最近也与息肉病表型相关,这在息肉病患者的临床、病因和遗传方面造成了异质性。 目的:使用全外显子测序研究怀疑患有息肉病但[基因名称1]和[基因名称2]基因无变异的患者潜在的变异情况。 方法:27名参与者纳入研究并进行种系全外显子测序。此外,收集了他们的临床病理、个人和家族病史数据。 结果:诊断时的平均年龄为51岁,大多数参与者患有息肉病的轻症形式(88.9%),63.0%被诊断为原发性肿瘤,主要是结直肠癌(76.5%)。在鉴定出的变异中,17个被分类为致病性或可能致病性(在12名参与者中),包括参与Wnt/β-连环蛋白信号通路的基因变异,如[基因名称6]、[基因名称7]和[基因名称8],以及DNA修复基因变异,如[基因名称9]、[基因名称10]和[基因名称11],还有一名19岁患有经典息肉病且有息肉家族史的患者在[基因名称12]基因上发现的变异。 结论:本研究在缺乏[基因名称1]和[基因名称2]基因种系致病性变异的患者中鉴定出了可能与息肉病相关的新基因。这些发现支持使用下一代测序进行筛查,将息肉病相关变异的范围扩展到这两个基因之外。
World J Gastroenterol. 2025-8-7
Fam Cancer. 2025-4-16
Dis Colon Rectum. 2025-7-1
Health Technol Assess. 2010-6
Endocr Rev. 2025-3-11
Blood Cancer Discov. 2024-11-1